Design, synthesis and X ‐ray structural studies of novel [acetonitrile‐benzyl‐3‐N‐(2, 4 dihydroxyphenylmethylene) hydrazinecarbodithioato‐κ3‐N′, S, O] nickel(ll) complex that potently inhibit cell proliferation through regulation of apoptosis related genes
In conclusion, the newly synthesized nickel(ll) complex has shown anti‐proliferative activity and can further be optimized to be used as a lead molecule for anticancer drug.
Source: Applied Organometallic Chemistry - Category: Chemistry Authors: Ronok Zahan,
Md. Sifat Rahi,
Md. Chanmiya Sheikh,
Ryuta Miyatake,
Ennio Zangrando,
Tarannum Naz,
Md. Al ‐Amin‐Al‐Azadul Islam,
Md Abu Reza Tags: FULL PAPER Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemistry | Genetics | Peritoneal Cancer | Study | Switzerland Health